Chemical Compound

(8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one/(8R,9R,10R,13R,14R,17S)-13-ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

CAS Registry Number 21508-50-9
返回搜索 申请报价
(8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one/(8R,9R,10R,13R,14R,17S)-13-ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one 结构式
Primary record

(8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one/(8R,9R,10R,13R,14R,17S)-13-ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

库存
9,755 克
纯度
98.8 %
CAS
21508-50-9

化合物标识与属性

CAS
21508-50-9
PubChem CID
71748888
SMILES
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@]34O
Canonical SMILES
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(O)[C@H]3CC[C@@]21CC

名称与同义词

  • 10-Hydroxylevonorgestrel
  • Levonorgestrel EP Impurity I
  • M8ZTL23HWP
  • 10beta-hydroxylevonorgestrel
  • UNII-M8ZTL23HWP
  • Levonorgestrel Impurity 20
  • 10|A-HydroxyLevonorgestrel
  • 10-Hydroxylevonorgestrel [EP]
  • 10|A-Hydroxy D-(-)-Norgestrel
  • Levonorgestrel impurity I [EP]
  • 21508-50-9
  • 10?-Hydroxy D-(-)-norgestrel
  • DTXSID40857732
  • ZMTZYQYDIREIIA-HXIANDDZSA-N
  • ZINC77293521
  • 10.BETA.-HYDROXYLEVONORGESTREL
  • 6beta-Deshydroxy-10beta-hydroxylevonorgestrel
  • 20402-62-4
  • 10-beta-Hydroxylevonorgestrel (and enantiomer)
  • 10-HYDROXYLEVONORGESTREL [EP IMPURITY]
  • 13-Ethyl-10,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
  • LEVONORGESTREL IMPURITY I [EP IMPURITY]
  • Levonorgestrel Impurity I (10-beta-Hydroxy Levonorgestrel)
  • (8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
  • 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-10,17-dihydroxy-, (17alpha)-
  • (17|A)-13-Ethyl-10,17-dihydroxy-18,19-dinorpregn-4-en-20-yn-3-one
  • 13-Ethyl-10,17-dihydroxy-18,19-dinor-17-pregn-4-en-20-yn-3-one
  • 13-Ethyl-10,17-dihydroxy-18,19-dinor-17|A-pregn-4-en-20-yn-3-one
  • 13-ETHYL-10,17-DIHYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE
  • 18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-10,17-DIHYDROXY-, (17.ALPHA.)-
  • (17a)?-?(+/-)?-13-Ethyl-?10,?17-?dihydroxy-18,?19-?dinorpregn-?4-?en-?20-?yn-?3-?one; Levonorgestrel EP Impurity I; (+/-)-13-ethyl-10,17-dihydroxy-18,19-Dinor-17a-pregn-4-en-20-yn-3-one
  • (1R,3aS,3bS,9aS,9bS,11aS)-11a-Ethyl-1-ethynyl-1,9a-dihydroxy-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one
  • (8S,9S,10S,13S,14S,17R)-13-Ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
  • (8S,9S,10S,13S,14S,17R)-13-ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one/(8R,9R,10R,13R,14R,17S)-13-ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
  • (8S,9S,10S,13S,14S,17R)-13-Ethyl-17-ethynyl-10,17-dihydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one